glp 1 alcohol use disorder Can semaglutide help reduce craving and consumption in adults with alcohol disorder?, A randomized clinical trial published in JAMA Psychiatry offers preliminary evidence. , 🔗 Read the GLP-1 receptor agonists are promising

What stands out is not just that these studies met their endpoints, but that many of them changed the question being asked from does it work? to how fast should this become standard? This level of impact signals a healthier, more productive late-stage pipeline and a clearer connection between innovation and patient benefit

Any changes people notice may be due to placebo effects, increased awareness around eating, or temporary water weight changes rather than true fat loss

In Vitro and ex Vivo Uptake of Glutathione (GSH) across the Intestinal Epithelium and Fate of Oral GSH after in vivo Supplementation

B7-33 is primarily studied for its anti-fibrotic effects, meaning it may help reduce excessive scarring and tissue hardening, common outcomes of chronic inflammation